Obi Umeh, MD, MSc, VP, Franchise Global Program Leader at Takeda, discusses interim results from a study investigating mezagitamab for the treatment of patients with IgA nephropathy. This…
Dana Rizk, MD, professor of medicine at the University of Alabama at Birmingham, discusses the approval of Fabhalta (iptacopan) for adults with IgA nephropathy. Iptacopan, a Factor B…
NEW YORK (Reuters Health) – Active surveillance (“watchful waiting”) of small renal masses offers short term results equivalent to those with immediate surgery, researchers from UK report in…
NEW YORK (Reuters Health) – Pooled data suggest that use of renin–angiotensin system (RAS) inhibitors, particularly angiotensin converting enzyme (ACE) inhibitors may increase the risk of angioedema, researchers…
NEW YORK (Reuters Health) – In a large randomized study of hemodialysis patients with new arteriovenous grafts, daily fish oil supplementation didn’t improve long-term graft patency. However, those…
NEW YORK (Reuters Health) – Older patients with small localized kidney tumors treated with partial nephrectomy live longer than those treated with radical nephrectomy, a new study suggests.…
NEW YORK (Reuters Health) – A population-based study conducted in Canada has uncovered an association between starting fibrate therapy and an increase in serum creatinine in older patients,…
NEW YORK (Reuters Health) – Kidney transplant recipients who are inoculated with autologous marrow-derived mesenchymal stem cells (MSC) have less risk of organ rejection and of opportunistic infection…
NEW YORK (Reuters Health) – Tight glycemic control in preterm babies who develop hyperglycemia should be avoided for now, until more data on the risks and benefits are…
NEW YORK (Reuters Health) – Early ischemic events are reduced in patients undergoing percutaneous coronary intervention for acute coronary syndrome when they’re treated with cangrelor rather than clopidogrel…
NEW YORK (Reuters Health) – Results of a meta-analysis indicate that patients with chronic kidney disease (CKD) derive little net benefit from antiplatelet therapy in terms of cardiovascular…
NEW YORK (Reuters Health) – The success of radiofrequency ablation (RFA) for small renal tumors is strongly dependent on tumor size, according to a study in the April…
